Mankind Pharma Limited has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of INR 13,768 Crores. This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian
Enabling ART centres/clinics to implement the requirements of the Assisted Reproductive Technology Regulations, 2021 for greater compliance….. Mumbai: Ahead of the World IVF Day, Bharat Serums and Vaccines Limited (BSV) a leading biopharmaceutical company in India has roped in Bureau Veritas (India) Pvt. Ltd. (BVIL), a
Bharat Serums and Vaccines Limited (BSV), in partnership with Indian Society of Assisted Reproduction (ISAR), Academy of Clinical Embryologists (ACE), Indian Fertility Society (IFS) and Institute of Medicine & Law, convened a two-day Conclave in Delhi on November 19 and 20. The Conclave focused on
Bharat Serums and Vaccines (BSV), a leading biopharmaceutical company in India reaffirms its commitment to spur innovation and scientific research through its world class R&D centre at Airoli, Maharashtra. The state-of-art centre was inaugurated by Shri Rajesh Tope, Maharashtra's Health Minister yesterday. Also present at
